• The Province of British Columbia and the Ministry of Health announced $2 million in funding to ensure that critical long-term Arthritis Research Canada studies can continue uninterrupted. Minister of Health, the Honourable Adrian Dix attended the 2019 ARThritis Soirée to make the announcement.
  • The Province of British Columbia is the first Canadian province to introduce a Biosimilars transition policy. Arthritis Research Canada scientists are conducting research to evaluate the impact of biosimilar transition policies and provide educational resources about biosimilars for people living with different types of inflammatory arthritis.